What's new

Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 6, Status: Authorised

Feb 13, 2025 - 12:51
 0
Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

Ray Chapman Motors Volvo wins Feefo customer service award

Next Article

Elliott builds £3.8bn stake in BP and seeks big asset sales

Related Posts

Human medicines European public assessment report (EPAR): Rivastigmine Sandoz, rivastigmine, Date of authorisation: 10/12/2009, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 4, 2025  0

Human medicines European public assessment report (EPAR): Jardiance, empagliflozin, Date of authorisation: 22/05/2014, Revision: 31, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 2, 2025  0

Human medicines European public assessment report (EPAR): Ronapreve, casirivimab,imdevimab, Date of authorisation: 12/11/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 9, 2025  0